AXA Investment Managers has restructured the AXA World Funds (WF) Framlington Health fund as a longevity-focused fund.
A sub fund of the AXA World Funds SICAV, the newly-named AXA WF Framlington Longevity Economy fund remains an equity mandate but now aims to achieve long-term capital growth by investing in companies linked to the ageing of the population and increasing life expectancy worldwide. The multi-cap fund holds companies focused on aged care, wellness and medical treatments as well as those benefiting from the increase in ‘silver spending', such as leisure activities, financial planning and aesthetics. Dani Saurymper, who has managed the $117.65m (£90.49m) fund since August 2015 and heads up...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
